Webinar Description
Dr. Younossi and expert panel provide an overview of the importance of liver fibrosis in NASH and timely noninvasive screening options. The goal of this activity is to highlight best practice in diagnosing and monitoring liver fibrosis and to improve physician confidence in their ability to use noninvasive techniques to identify patients at risk of liver fibrosis progression.
Key learning objectives
- Know the guideline recommendations for screening, prognosis, and diagnosis of liver fibrosis
- Learn the appropriate diagnostic and monitoring techniques for liver fibrosis
- Gain more confidence in using noninvasive techniques in clinical practice to identify patients with advanced fibrosis
Expert Panel
Moderator
Zobair Younossi, MD
Vice President of Research Inova Health SystemFalls Church, Virginia, United States
Panelists
Jörn Schattenberg, MD
Director, Metabolic Liver Research Program
Johannes Gutenberg-Universität Mainz
Mainz, Germany
Jerome Boursier, MD
Academic Hepatologist
University of Angers
Angers, France
Mazen Noureddin, MD
Director, Cedars-Sinai Fatty Liver Program
Cedars-Sinai Medical Center
Los Angeles, California, United States